🇺🇸 FDA
Pipeline program

galidesivir

BCX4430-106

Phase 1 small_molecule completed

Quick answer

galidesivir for Marburg Virus Disease is a Phase 1 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOCRYST PHARMACEUTICALS INC
Indication
Marburg Virus Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials